Skip to main content
Fig. 4 | World Journal of Surgical Oncology

Fig. 4

From: Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report

Fig. 4

Histological findings after the combined multidrug therapy including atezolizumab. A Viable clear cell carcinoma (WHO/ISUP nuclear grade 2) in the left ureteral wall. HE, reduced from 100 × . B The right lung metastasis resected by partial lobectomy via a small thoracic incision also revealed vivid features of clear cell carcinoma. HE, reduced from 100x

Back to article page